Table 1.

Clinical Reviews of LRTI Death Reports Following RV1 or RV5 Vaccination, VAERS 2008–2016.

No.	Age (weeks)	Sex	Year	Vaccine Group	Other vaccines	Onset Interval (days)	Past Medical History/ Family History	Pre-existing Conditions	Cause of Death
1	9	F	2008	RV5 and PCV7	DTaP HepB IPV Hib	3	Sick contacts at home, tobacco smoking at home	RSV bronchiolitis, tinea corporis	Viral pneumonia
2	8	M	2012	RV5 and PCV7	DTaP HepB IPV Hib	1	None	Congestion, cough 3 days prior to vaccination	Sudden unexplained infant death. Other findings: parainfluenza (type 3) bronchiolitis
3	7	M	2012	RV5 and PCV13	DTaP HepB IPV Hib	1	None	None	Bilateral pneumonia (Group A, Streptococcus pyogenes)
4	11	F	2014	RV5 and PCV13	DTaP HepB IPV Hib	13	Unknown	Unknown	Respiratory insufficiency secondary to early bronchopneumonia and chronic interstitial pneumonitis, SIDS

RSV, respiratory syncytial virus; SIDS, sudden infant death syndrome